Dexmedetomidine for analgesia and sedation in newborn infants receiving mechanical ventilation
CONCLUSIONS: Despite the increasing use of dexmedetomidine, there is insufficient evidence supporting its routine use for analgesia and sedation in newborn infants on mechanical ventilation. Furthermore, data on dexmedetomidine safety are scarce, and there are no data available on its long-term effects. Future studies should address the efficacy, safety, and long-term effects of dexmedetomidine as a single drug therapy for sedation and analgesia in newborn infants.PMID:38695625 | DOI:10.1002/14651858.CD012361.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Jia Yi Lim Chin Jin Ker Nai Ming Lai Olga Romantsik Michelle Fiander Kenneth Tan Source Type: research
More News: Brain | Children | Databases & Libraries | Fentanyl | General Medicine | Hypothermia | Morphine | Neurology | Neurosurgery | Perinatology & Neonatology | Study